US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 937.610
  • +34.130+3.78%
Close May 2 16:00 ET
  • 929.900
  • -7.710-0.82%
Pre 04:38 ET
103.31BMarket Cap27.68P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
-29.18%5.01B
-27.51%1.72B
-81.58%628.9M
-9.94%564.4M
Net income from continuing operations
-11.71%722M
-8.87%3.95B
-3.13%1.16B
-23.40%1.01B
13.65%968.4M
-15.99%817.8M
-46.28%4.34B
-46.29%1.2B
-19.39%1.32B
-72.50%852.1M
Operating gains losses
17.71%196.1M
623.91%266.4M
27.92%-58.1M
150.10%127M
-81.43%30.9M
-18.53%166.6M
109.51%36.8M
-158.58%-80.6M
-965.19%-253.5M
140.63%166.4M
Depreciation and amortization
14.67%114.1M
23.32%421M
12.89%113M
13.82%105.4M
38.58%103.1M
33.92%99.5M
19.29%341.4M
34.36%100.1M
26.50%92.6M
4.64%74.4M
Deferred tax
12.06%-190.4M
-12.25%-837.8M
-2.36%-286.3M
-46.67%-125.7M
-34.17%-209.3M
3.78%-216.5M
-407.41%-746.4M
-35.84%-279.7M
-1,324.29%-85.7M
-474.10%-156M
Other non cash items
-99.51%100K
-100.02%-100K
-110.36%-17.5M
-119.44%-11.8M
-96.55%8.6M
-75.56%20.6M
-1.00%563M
-44.46%169M
-15.46%60.7M
51.92%249M
Change In working capital
82.86%440.5M
61.32%-94.1M
-116.07%-61.4M
71.18%-192.3M
89.59%-81.3M
-70.74%240.9M
87.30%-243.3M
207.48%382M
-145.60%-667.2M
68.56%-781.3M
-Change in receivables
112.66%446.8M
-147.87%-338.8M
-137.66%-82.7M
-19.80%-463.5M
99.16%-2.7M
-82.46%210.1M
136.72%707.8M
137.57%219.6M
-125.11%-386.9M
88.59%-322.4M
-Change in inventory
-232.91%-155.8M
60.99%-271.7M
67.22%-47.3M
65.46%-77.2M
58.18%-100.4M
47.18%-46.8M
-40.91%-696.5M
11.85%-144.3M
-104.86%-223.5M
-867.09%-240.1M
-Change in prepaid assets
-1,316.36%-77.9M
19.18%-120.1M
778.61%164.3M
-327.31%-275.5M
98.60%-3.4M
87.72%-5.5M
38.26%-148.6M
-75.43%18.7M
410.77%121.2M
-6.98%-243.7M
-Change in payables and accrued expense
-7.14%110.5M
532.51%598.6M
-139.90%-138.7M
460.95%578.6M
152.72%39.7M
147.52%119M
-115.98%-138.4M
-4.95%347.6M
-309.00%-160.3M
-116.43%-75.3M
-Change in other working capital
425.63%116.9M
16.98%37.9M
172.15%43M
355.93%45.3M
-114.47%-14.5M
-477.89%-35.9M
126.96%32.4M
-21.63%-59.6M
-176.56%-17.7M
27.16%100.2M
Cash from discontinued investing activities
Operating cash flow
10.60%1.51B
-8.39%4.59B
-36.64%1.09B
77.18%1.11B
81.15%1.02B
-34.93%1.37B
-29.18%5.01B
-27.51%1.72B
-81.58%628.9M
-9.94%564.4M
Investing cash flow
Cash flow from continuing investing activities
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
29.72%-3.78B
7.70%-1.86B
107.89%192.3M
-429.01%-413.9M
Capital expenditure reported
24.86%-133.9M
-21.78%-718.6M
-65.18%-251.4M
-23.51%-176M
26.43%-113M
-25.67%-178.2M
-6.92%-590.1M
1.74%-152.2M
-6.98%-142.5M
-3.43%-153.6M
Net intangibles purchase and sale
72.35%-27.9M
79.76%-207.8M
37.90%-62.1M
97.42%-23.9M
---20.9M
---100.9M
---1.03B
---100M
---926.8M
--0
Net business purchase and sale
----
76.16%-54.9M
---3.8M
----
----
----
---230.3M
--0
----
----
Net investment purchase and sale
-3,614.52%-1.53B
-13.75%-2.2B
115.64%251.1M
-119.44%-245.3M
-7,410.00%-2.25B
102.78%43.4M
59.91%-1.94B
13.58%-1.61B
154.72%1.26B
-110.94%-30M
Cash from discontinued investing activities
Investing cash flow
-615.78%-1.69B
15.84%-3.19B
96.44%-66.2M
-358.09%-496.3M
-476.69%-2.39B
86.18%-235.7M
29.72%-3.78B
7.70%-1.86B
107.89%192.3M
-429.01%-413.9M
Financing cash flow
Cash flow from continuing financing activities
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
Net common stock issuance
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
Cash from discontinued financing activities
Financing cash flow
114.60%47.1M
-77.41%-1.79B
-80.17%-446.1M
43.82%-407.3M
-507.52%-614.2M
-598.45%-322.5M
-0.32%-1.01B
72.69%-247.6M
-288.12%-725M
14.47%-101.1M
Net cash flow
Beginning cash position
-12.23%2.74B
7.64%3.12B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
7.64%3.12B
31.30%2.9B
1.74%3.5B
63.51%3.41B
131.61%3.36B
Current changes in cash
-115.75%-127.5M
-272.25%-381.2M
249.82%577.4M
119.02%210.7M
-4,105.47%-1.98B
75.54%809.4M
-67.96%221.3M
29.52%-385.4M
-92.93%96.2M
-92.21%49.4M
Effect of exchange rate changes
---500K
---400K
--200K
---200K
---400K
--0
--0
--0
--0
----
End cash Position
-33.57%2.61B
-12.23%2.74B
-12.23%2.74B
-38.36%2.16B
-42.80%1.95B
16.96%3.93B
7.64%3.12B
7.64%3.12B
1.74%3.5B
63.51%3.41B
Free cash flow
24.09%1.35B
7.93%3.67B
-47.11%776.2M
307.63%914.4M
116.29%888.5M
-44.46%1.09B
-47.96%3.4B
-33.82%1.47B
-113.43%-440.4M
-14.09%410.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B-29.18%5.01B-27.51%1.72B-81.58%628.9M-9.94%564.4M
Net income from continuing operations -11.71%722M-8.87%3.95B-3.13%1.16B-23.40%1.01B13.65%968.4M-15.99%817.8M-46.28%4.34B-46.29%1.2B-19.39%1.32B-72.50%852.1M
Operating gains losses 17.71%196.1M623.91%266.4M27.92%-58.1M150.10%127M-81.43%30.9M-18.53%166.6M109.51%36.8M-158.58%-80.6M-965.19%-253.5M140.63%166.4M
Depreciation and amortization 14.67%114.1M23.32%421M12.89%113M13.82%105.4M38.58%103.1M33.92%99.5M19.29%341.4M34.36%100.1M26.50%92.6M4.64%74.4M
Deferred tax 12.06%-190.4M-12.25%-837.8M-2.36%-286.3M-46.67%-125.7M-34.17%-209.3M3.78%-216.5M-407.41%-746.4M-35.84%-279.7M-1,324.29%-85.7M-474.10%-156M
Other non cash items -99.51%100K-100.02%-100K-110.36%-17.5M-119.44%-11.8M-96.55%8.6M-75.56%20.6M-1.00%563M-44.46%169M-15.46%60.7M51.92%249M
Change In working capital 82.86%440.5M61.32%-94.1M-116.07%-61.4M71.18%-192.3M89.59%-81.3M-70.74%240.9M87.30%-243.3M207.48%382M-145.60%-667.2M68.56%-781.3M
-Change in receivables 112.66%446.8M-147.87%-338.8M-137.66%-82.7M-19.80%-463.5M99.16%-2.7M-82.46%210.1M136.72%707.8M137.57%219.6M-125.11%-386.9M88.59%-322.4M
-Change in inventory -232.91%-155.8M60.99%-271.7M67.22%-47.3M65.46%-77.2M58.18%-100.4M47.18%-46.8M-40.91%-696.5M11.85%-144.3M-104.86%-223.5M-867.09%-240.1M
-Change in prepaid assets -1,316.36%-77.9M19.18%-120.1M778.61%164.3M-327.31%-275.5M98.60%-3.4M87.72%-5.5M38.26%-148.6M-75.43%18.7M410.77%121.2M-6.98%-243.7M
-Change in payables and accrued expense -7.14%110.5M532.51%598.6M-139.90%-138.7M460.95%578.6M152.72%39.7M147.52%119M-115.98%-138.4M-4.95%347.6M-309.00%-160.3M-116.43%-75.3M
-Change in other working capital 425.63%116.9M16.98%37.9M172.15%43M355.93%45.3M-114.47%-14.5M-477.89%-35.9M126.96%32.4M-21.63%-59.6M-176.56%-17.7M27.16%100.2M
Cash from discontinued investing activities
Operating cash flow 10.60%1.51B-8.39%4.59B-36.64%1.09B77.18%1.11B81.15%1.02B-34.93%1.37B-29.18%5.01B-27.51%1.72B-81.58%628.9M-9.94%564.4M
Investing cash flow
Cash flow from continuing investing activities -615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M29.72%-3.78B7.70%-1.86B107.89%192.3M-429.01%-413.9M
Capital expenditure reported 24.86%-133.9M-21.78%-718.6M-65.18%-251.4M-23.51%-176M26.43%-113M-25.67%-178.2M-6.92%-590.1M1.74%-152.2M-6.98%-142.5M-3.43%-153.6M
Net intangibles purchase and sale 72.35%-27.9M79.76%-207.8M37.90%-62.1M97.42%-23.9M---20.9M---100.9M---1.03B---100M---926.8M--0
Net business purchase and sale ----76.16%-54.9M---3.8M---------------230.3M--0--------
Net investment purchase and sale -3,614.52%-1.53B-13.75%-2.2B115.64%251.1M-119.44%-245.3M-7,410.00%-2.25B102.78%43.4M59.91%-1.94B13.58%-1.61B154.72%1.26B-110.94%-30M
Cash from discontinued investing activities
Investing cash flow -615.78%-1.69B15.84%-3.19B96.44%-66.2M-358.09%-496.3M-476.69%-2.39B86.18%-235.7M29.72%-3.78B7.70%-1.86B107.89%192.3M-429.01%-413.9M
Financing cash flow
Cash flow from continuing financing activities 114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M
Net common stock issuance 114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M
Cash from discontinued financing activities
Financing cash flow 114.60%47.1M-77.41%-1.79B-80.17%-446.1M43.82%-407.3M-507.52%-614.2M-598.45%-322.5M-0.32%-1.01B72.69%-247.6M-288.12%-725M14.47%-101.1M
Net cash flow
Beginning cash position -12.23%2.74B7.64%3.12B-38.36%2.16B-42.80%1.95B16.96%3.93B7.64%3.12B31.30%2.9B1.74%3.5B63.51%3.41B131.61%3.36B
Current changes in cash -115.75%-127.5M-272.25%-381.2M249.82%577.4M119.02%210.7M-4,105.47%-1.98B75.54%809.4M-67.96%221.3M29.52%-385.4M-92.93%96.2M-92.21%49.4M
Effect of exchange rate changes ---500K---400K--200K---200K---400K--0--0--0--0----
End cash Position -33.57%2.61B-12.23%2.74B-12.23%2.74B-38.36%2.16B-42.80%1.95B16.96%3.93B7.64%3.12B7.64%3.12B1.74%3.5B63.51%3.41B
Free cash flow 24.09%1.35B7.93%3.67B-47.11%776.2M307.63%914.4M116.29%888.5M-44.46%1.09B-47.96%3.4B-33.82%1.47B-113.43%-440.4M-14.09%410.8M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg